n/a
Abstract Title:

Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence.

Abstract Source:

Fundam Clin Pharmacol. 2022 Apr 5. Epub 2022 Apr 5. PMID: 35384044

Abstract Author(s):

Farid Moradian, Mohammad Hossein Pourhanifeh, Saeed Mehrzadi, Arman Karimi-Behnagh, Azam Hosseinzadeh

Article Affiliation:

Farid Moradian

Abstract:

Hematological malignancies including leukemia, multiple myeloma, and lymphoma are known as leading causes of death around the world. Despite all developments in cancer management, current therapeutic methods are still relatively inefficient, leading to the heavy financial burdens for public health systems. Strategic attempts in clinical practice must be based on three serious goals including (1) increasing the efficacy of treatments and decreasing their side-effects; (2) decreasing financial price of treatments and related morbidity and mortality rates; and (3) improving life quality and survival of affected patients. Melatonin, a multipotential neurohormone mainly secreted by the pineal gland, has recently been shown to play essential roles in the treatment of various human diseases. Moreover, it possesses anticancer impacts and acts through regulation of underlying cellular and molecular mechanisms. In this article, we review mechanistic roles and beneficial effects of melatonin against hematological cancers, especially lymphoma.

Study Type : Review
Additional Links
Pharmacological Actions : Chemotherapeutic : CK(2328) : AC(1407)

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.